Find information on sensory hearing loss diagnosis, including clinical documentation, medical coding, and healthcare resources. Learn about sensorineural hearing loss, auditory neuropathy, cochlear damage, hearing thresholds, audiometry testing, and ICD-10 codes H90-H91 related to hearing impairment. Explore causes, symptoms, and treatment options for sensory neural hearing loss and improve your understanding of audiological evaluations and hearing healthcare management. This resource offers guidance for healthcare professionals on accurate diagnosis and documentation of sensory hearing loss.
Hearing loss due to inner ear (cochlea or auditory nerve) damage.
Reduced hearing sensitivity, tinnitus, speech difficulty, difficulty hearing in noise.
Audiology clinics, ENT offices, hospitals, hearing aid centers.
Complete code families applicable to H90.5
| Description | When to use |
|---|---|
| Inner ear hearing loss | Use for hearing loss due to cochlear or auditory nerve damage. Sensorineural deafness, SNHL |
| Conductive hearing loss | Use when sound conduction to inner ear is blocked. Outer/middle ear issues, cerumen impaction, otosclerosis |
| Mixed hearing loss | Use when both sensorineural and conductive hearing loss are present. Combined hearing impairment |
Incorrect coding for right ear, left ear, or bilateral hearing loss (H90.3, H90.4, H90.5) impacting reimbursement and data accuracy.
Miscoding conductive hearing loss (H90.2) as sensorineural (H90.3-H90.5) leading to inaccurate clinical documentation and quality metrics.
Using unspecified codes (H91.9) when a more specific sensorineural hearing loss diagnosis is documented, hindering data analysis and revenue cycle.
Verify ICD-10-CM code H90.x matches audiogram findings
Confirm documented history and physical exam aligns with sensorineural hearing loss
Check for appropriate referrals (audiology, ENT) documented in plan
Review medication list for ototoxic drugs contributing to hearing loss
Patient presents with complaints consistent with sensory hearing loss, also known as sensorineural hearing loss SNHL. Onset of hearing difficulty was reported as gradual progressive intermittent sudden or fluctuating, impacting the patients ability to understand speech in quiet and noisy environments. Symptoms include difficulty hearing high-pitched sounds, tinnitus, and or dizziness. The patient denies experiencing ear pain, discharge, or fullness. Otoscopic examination revealed normal tympanic membranes bilaterally. Pure-tone audiometry PTA confirms the presence of sensorineural hearing loss, demonstrating thresholds exceeding dB HL at frequencies of Hz. Speech audiometry revealed a word recognition score of percent. Differential diagnoses considered include presbycusis, noise-induced hearing loss NIHL, ototoxicity, Menieres disease, acoustic neuroma, and auditory neuropathy spectrum disorder. Based on the patients history, examination, and audiometric findings, the diagnosis of sensorineural hearing loss is established. The patient was counseled on the nature and prognosis of sensorineural hearing loss, as well as management options, including hearing aids, assistive listening devices ALDs, cochlear implants, and communication strategies. Referral to an audiologist and or otolaryngologist is recommended for further evaluation and management. ICD-10 code H90. Return to clinic scheduled in weeks months for follow-up and reassessment of hearing status.
Differentiating sensorineural hearing loss (SNHL) from other types like conductive hearing loss requires a multi-faceted approach. Pure tone audiometry is the foundational test, revealing the degree and configuration of hearing loss. However, to pinpoint SNHL specifically, clinicians should incorporate speech audiometry (evaluating speech recognition thresholds and word recognition scores), tympanometry (assessing middle ear function to rule out conductive components), and acoustic reflex testing (evaluating the stapedius muscle reflex, often absent or elevated in SNHL). Auditory brainstem response (ABR) testing can further localize the site of lesion within the auditory pathway, distinguishing cochlear from retrocochlear pathologies. For patients presenting with asymmetric SNHL, MRI is crucial to exclude acoustic neuroma or other retrocochlear lesions. Consider implementing a comprehensive test battery including these procedures to accurately diagnose SNHL and guide appropriate management. Explore how combining these tests offers a more precise diagnosis compared to relying on pure tone audiometry alone.
Counseling patients with SNHL requires a patient-centered approach that considers their individual needs and preferences. While amplification with hearing aids remains the cornerstone of management for most patients, discussing both amplification and non-amplification options is essential for informed decision-making. Amplification options include traditional hearing aids, bone-anchored hearing aids (BAHAs), and cochlear implants, each with its specific indications and benefits. Non-amplification strategies include assistive listening devices (ALDs), communication strategies training, and, in specific cases, sign language. When discussing amplification, emphasize the importance of realistic expectations and the iterative process of fitting and adjustment. For patients hesitant about hearing aids, explore the benefits of ALDs and communication strategies as valuable adjuncts or alternatives. Learn more about the latest advancements in hearing aid technology, including directional microphones, noise reduction features, and Bluetooth connectivity, to effectively address patient concerns and tailor recommendations. Consider implementing a shared decision-making model to ensure patient satisfaction and optimal outcomes.
While routine SNHL cases can often be managed by audiologists, certain red flags necessitate urgent referral to an otolaryngologist or neurotologist. These include sudden onset SNHL (requiring prompt evaluation for potential reversible causes), asymmetric SNHL (raising suspicion for retrocochlear pathology), rapidly progressive SNHL, pulsatile tinnitus (suggesting possible vascular abnormalities), dizziness or vertigo accompanying hearing loss (indicating potential inner ear or vestibular involvement), and facial numbness or weakness (raising concern for neurological conditions). Educating patients about these red flags is crucial for early detection and intervention. Clinicians should emphasize the importance of immediate medical attention if any of these symptoms arise. Explore how incorporating a standardized checklist of red flags into your audiological evaluation can improve patient safety and facilitate timely referrals. Learn more about the collaborative management of complex SNHL cases between audiologists and specialized physicians.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.